Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Alessandro Serretti
University of Bologna
766Publications
66H-index
19kCitations
Publications 766
Newest
Published on Jun 1, 2019in European Neuropsychopharmacology 4.47
Filippo Corponi3
Estimated H-index: 3
(UNIBO: University of Bologna),
Chiara Fabbri1
Estimated H-index: 1
('KCL': King's College London)
+ 5 AuthorsAlessandro Serretti66
Estimated H-index: 66
(UNIBO: University of Bologna)
Abstract Second generation antipsychotics (SGAs) are effective options in the treatment of schizophrenia and mood disorders, each with characteristic efficacy and safety features. In order to optimize the balance between efficacy and side effects, it is of upmost importance to match compound specificity against patient clinical profile. As the number of SGAs increased, this review can assist physicians in the prescription of three novel SGAs already on the market, namely lurasidone, brexpiprazol...
Marco Calabrò8
Estimated H-index: 8
,
Laura Mandelli34
Estimated H-index: 34
(UNIBO: University of Bologna)
+ -3 AuthorsChi-Un Pae37
Estimated H-index: 37
(Catholic University of Korea)
Gernot Fugger3
Estimated H-index: 3
,
Markus Dold12
Estimated H-index: 12
+ 8 AuthorsR. Frey14
Estimated H-index: 14
Abstract Objective The major aim of this multicenter study of the European Group for the Study of Resistant Depression (GSRD) was to elucidate associations between major depressive disorder (MDD) and comorbid diabetes. Methods Demographic and clinical information of 1410 patients with a primary MDD diagnosis according to DSM-IV were retrieved cross-sectionally between 2012 and 2016. By applying descriptive statistics, analyses of covariance (ANCOVA) and binary logistic regression analyses, a com...
Published on Jul 25, 2019in World Journal of Biological Psychiatry 4.04
Lucie Bartova9
Estimated H-index: 9
(Medical University of Vienna),
Markus Dold12
Estimated H-index: 12
(Medical University of Vienna)
+ 9 AuthorsStuart A. Montgomery52
Estimated H-index: 52
(Lond: University of London)
Published on Apr 1, 2019in International Clinical Psychopharmacology 1.64
Paolo Olgiati14
Estimated H-index: 14
,
Alessandro Serretti66
Estimated H-index: 66
+ 5 AuthorsJulien Mendlewicz64
Estimated H-index: 64
Published on Mar 1, 2019in International Clinical Psychopharmacology 1.64
Giulio Perugi43
Estimated H-index: 43
,
Pietro De Rossi9
Estimated H-index: 9
+ 4 AuthorsAlessandro Serretti2
Estimated H-index: 2
Published on Jun 28, 2019
Chiara Fabbri1
Estimated H-index: 1
,
Alessandro Serretti66
Estimated H-index: 66
Pharmacogenetic testing can provide helpful guidance in the choice of treatment and should be interpreted as a decision-support tool to assist in thoughtful implementation of good clinical care.
Domenico De Donatis (UNIBO: University of Bologna), Vincenzo Florio4
Estimated H-index: 4
+ 4 AuthorsAndreas Conca21
Estimated H-index: 21
Abstract Background Major Depressive Disorder (MDD) is associated with a high rate of inadequate treatment response, which is mainly due to the large inter-individual genetic variability in pharmacokinetic and pharmacodynamic targets of antidepressant drugs. Little is still known about the exact association between plasma level of first-line antidepressants and clinical response. This is particularly true for duloxetine, a dual serotonin and norepinephrine reuptake inhibitor recommended as first...
Published on Apr 1, 2019in European Neuropsychopharmacology 4.47
Gernot Fugger3
Estimated H-index: 3
,
Markus Dold12
Estimated H-index: 12
+ 8 AuthorsStuart A. Montgomery52
Estimated H-index: 52
Abstract The objective of the present multicenter study was to elucidate relevant associations between major depressive disorder (MDD) and comorbid hypertension that are known for their frequent co-occurrence and interaction with regard to functional disability. Demographic and clinical information of altogether 1410 patients were retrieved cross-sectionally. Consecutively, a comparison of patient characteristics between MDD subjects with and without comorbid hypertension were conducted by descr...
Published on Jun 1, 2019in Journal of Affective Disorders 4.08
Martina Balestri8
Estimated H-index: 8
,
Stefano Porcelli14
Estimated H-index: 14
+ 31 AuthorsMarco Di Nicola21
Estimated H-index: 21
Abstract Background : personality features have been repeatedly associated with depression treatment outcome in Major Depressive Disorder (MDD), however conclusive results are still lacking. Moreover, as for Bipolar Disorder (BD), results are only few and preliminary. Aim : the aim of the present study was to perform an exploratory investigation of the influence of personality traits as assessed by the Temperament and Character Inventory (TCI), on principal depression treatment outcomes (non rem...
12345678910